We just received data on a new analyst forecast for $CGBD. Raymond James gave a rating of 'Market Perform' for $CGBD.
$CGBD Analyst Ratings
Wall Street analysts have issued reports on $CGBD in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 04/24/2025
To track analyst ratings and price targets for $CGBD, check out Quiver Quantitative's $CGBD forecast page.
$CGBD Price Targets
Multiple analysts have issued price targets for $CGBD recently. We have seen 3 analysts offer price targets for $CGBD in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- Mitchel Penn from Oppenheimer set a target price of $15.0 on 05/08/2025
- Finian O'Shea from Wells Fargo set a target price of $13.0 on 05/08/2025
- Melissa Wedel from JP Morgan set a target price of $14.0 on 04/24/2025
$CGBD Hedge Fund Activity
We have seen 56 institutional investors add shares of $CGBD stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CREATIVE PLANNING added 4,858,884 shares (+36290.1%) to their portfolio in Q1 2025, for an estimated $78,616,743
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 410,472 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,615,256
- CITADEL ADVISORS LLC added 175,568 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,840,690
- ETHOS FINANCIAL GROUP, LLC added 171,871 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,780,872
- BANK OF AMERICA CORP /DE/ removed 130,827 shares (-11.0%) from their portfolio in Q1 2025, for an estimated $2,116,780
- HERBST GROUP, LLC removed 127,180 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,057,772
- DOLIVER ADVISORS, LP added 122,581 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,676,908
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.